The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?

by Yenan Mo, Yenan Mo, Zhaoyu Lu, Zhaoyu Lu, Lixin Wang, Chunlan Ji, Chunlan Ji, Chuan Zou, Xusheng Liu
Published 2020-12-01

Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway

by Yenan Mo, Xina Jie, Lixin Wang, Chunlan Ji, Yueyu Gu, Zhaoyu Lu, Xusheng Liu
Published 2021-08-01

Shenfu Injection for Intradialytic Hypotension: A Systematic Review and Meta-Analysis

by Yenan Mo, Xusheng Liu, Xindong Qin, Jing Huang, Zhiren He, Junjie Lin, Qinqing Hu, Youqing Cai, Zhuangzhu Liu, Lixin Wang
Published 2014-01-01

Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats

by Yenan Mo, Huang Sun, Lei Zhang, Lei Zhang, Wenjia Geng, Wenjia Geng, Lixin Wang, Lixin Wang, Chuan Zou, Chuan Zou, Yuchi Wu, Yuchi Wu, Chunlan Ji, Xusheng Liu, Xusheng Liu, Zhaoyu Lu, Zhaoyu Lu
Published 2021-05-01

Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study

by Zhiren He, Haijing Hou, Difei Zhang, Yenan Mo, La Zhang, Guobin Su, Junjie Lin, Liming Lu, Jingyao Huang, Yewen Gu, Ying Zhang, Jingxia Lin, Fengling Yuan, Yu Peng, Hui Liang, Daixin Zhao, Fuhua Lu, Xusheng Liu, Lixin Wang
Published 2020-09-01